Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer

Epidemiology

Volumn 10, Issue 6, 1999, Pages 761-763

  Wittenberg, Linda ^a   Cook, Linda S ^b   Rossing, Mary Anne ^c,d   Weiss, Noel S ^c,d  

^a Natl Org Qual Improvement H   (Netherlands)

^b UNIVERSITY OF CALGARY   (Canada)

^c USA   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Histology; Oral contraceptives; Ovarian neoplasms; Parity

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; OVARY CARCINOMA; POPULATION RESEARCH; PREGNANCY; PRIORITY JOURNAL; REPRODUCTION; RISK ASSESSMENT;

EID: 0032740895     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199911000-00018     Document Type: Article

References (13)

1. Risch AR, Marret LD, Jain M, Howe GR. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol 1996;144:363-372.
2. Cook LS, Kamb ML, Weiss NS. Perineal powder exposure and the risk of ovarian cancer. Am J Epidemiol 1997;145:459-465.
3. Percy C, van Holten V, Muir C, eds. International Classification of Diseases for Oncology. 2nd ed. World Health Organization, Geneva, 1990.
4. Waksberg J. Sampling methods for random digit dialing. J Am Stat Soc 1978;73:40-46.
5. Breslow NE, Day NE, eds. Statistical Methods in Cancer Research, vol 1. The Analysis of Case-Control Studies. IARC Scientific Pub No. 32. Lyon: International Agency for Research on Cancer, 1980;192-246.
6. Harris R, Whittemore AS, Itnyre J, and the Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Am J Epidemiol 1992;136:1204-1211.
7. Cramer DW, Hutchison GB, Welch WR, Scully RE, Ryan KJ. Determinants of ovarian cancer risk. I. Reproductive experience and family history. J Natl Cancer Inst 1983;71:711-716.
8. Kvåle G, Heuch I, Nilssen S, Beral V. Reproductive factors and risk of ovarian cancer: a prospective study. Int J Cancer 1988;42:246-251.
9. Cramer DW, Hutchison GB, Welch WR, Beral V. Factors affecting the association of oral contraceptives and ovarian cancer. N Engl J Med 1982; 307:1047-1051.
10. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Epithelial ovarian cancer and combined oral contraceptives. Int J Epidemiol 1989;18:538-545.
11. Weiss NS, Lyon JL, Liff JM, Vollmer WM, Daling JR. Incidence of ovarian cancer in relation to the use of oral contraceptives. Int J Cancer 1981;28: 669-671.
12. Weiss NS, Homonchuck T, Young JL. Incidence of the histologic types of ovarian cancer. Gynec Oncol 1977;5:161-167.
13. Weiss NS, Peterson AS. Racial variation in the incidence of ovarian cancer in the United States. Am J Epidemiol 1978;107:91-95.